0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Anti-Helicobacter Pylori Antibody Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-4Y15208
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Anti Helicobacter Pylori Antibody Market Research Report 2023
BUY CHAPTERS

Global Recombinant Anti-Helicobacter Pylori Antibody Market Research Report 2025

Code: QYRE-Auto-4Y15208
Report
May 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Anti-Helicobacter Pylori Antibody Market

The global market for Recombinant Anti-Helicobacter Pylori Antibody was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Recombinant anti-Helicobacter pylori antibodies are synthetic antibodies that are designed to specifically target and bind to proteins or other molecules produced by Helicobacter pylori (H. pylori), a bacterium that colonizes the human stomach and is associated with various gastrointestinal diseases, including gastritis, peptic ulcers, and gastric cancer.
North American market for Recombinant Anti-Helicobacter Pylori Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Recombinant Anti-Helicobacter Pylori Antibody is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Recombinant Anti-Helicobacter Pylori Antibody include Thermo Fisher, Ray Biotech, MyBioSource, ImmunoDiagnostics, Hycult Biotech, Fine Test, Enzo Biochem, Eagle Diagnostics, Creative Biolabs, Boster Bio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Anti-Helicobacter Pylori Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Anti-Helicobacter Pylori Antibody.
The Recombinant Anti-Helicobacter Pylori Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Anti-Helicobacter Pylori Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Anti-Helicobacter Pylori Antibody manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Recombinant Anti-Helicobacter Pylori Antibody Market Report

Report Metric Details
Report Name Recombinant Anti-Helicobacter Pylori Antibody Market
Segment by Type
  • 1 mg
  • 2 mg
  • 5 mg
  • Others
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher, Ray Biotech, MyBioSource, ImmunoDiagnostics, Hycult Biotech, Fine Test, Enzo Biochem, Eagle Diagnostics, Creative Biolabs, Boster Bio, BioVendor Group, Abcam
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Recombinant Anti-Helicobacter Pylori Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Recombinant Anti-Helicobacter Pylori Antibody in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Recombinant Anti-Helicobacter Pylori Antibody Market report?

Ans: The main players in the Recombinant Anti-Helicobacter Pylori Antibody Market are Thermo Fisher, Ray Biotech, MyBioSource, ImmunoDiagnostics, Hycult Biotech, Fine Test, Enzo Biochem, Eagle Diagnostics, Creative Biolabs, Boster Bio, BioVendor Group, Abcam

What are the Application segmentation covered in the Recombinant Anti-Helicobacter Pylori Antibody Market report?

Ans: The Applications covered in the Recombinant Anti-Helicobacter Pylori Antibody Market report are Medical Diagnosis, Scientific Research, Others

What are the Type segmentation covered in the Recombinant Anti-Helicobacter Pylori Antibody Market report?

Ans: The Types covered in the Recombinant Anti-Helicobacter Pylori Antibody Market report are 1 mg, 2 mg, 5 mg, Others

Recommended Reports

Helicobacter Pylori Diagnostics

Recombinant Antibody Markets

Gastric Disease Treatments

1 Recombinant Anti-Helicobacter Pylori Antibody Market Overview
1.1 Product Definition
1.2 Recombinant Anti-Helicobacter Pylori Antibody by Type
1.2.1 Global Recombinant Anti-Helicobacter Pylori Antibody Market Value Comparison by Type (2024 VS 2031)
1.2.2 1 mg
1.2.3 2 mg
1.2.4 5 mg
1.2.5 Others
1.3 Recombinant Anti-Helicobacter Pylori Antibody by Application
1.3.1 Global Recombinant Anti-Helicobacter Pylori Antibody Market Value by Application (2024 VS 2031)
1.3.2 Medical Diagnosis
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Recombinant Anti-Helicobacter Pylori Antibody Market Size Estimates and Forecasts
1.4.1 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue 2020-2031
1.4.2 Global Recombinant Anti-Helicobacter Pylori Antibody Sales 2020-2031
1.4.3 Global Recombinant Anti-Helicobacter Pylori Antibody Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Recombinant Anti-Helicobacter Pylori Antibody Market Competition by Manufacturers
2.1 Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Manufacturers (2020-2025)
2.2 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Recombinant Anti-Helicobacter Pylori Antibody Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Recombinant Anti-Helicobacter Pylori Antibody, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Recombinant Anti-Helicobacter Pylori Antibody, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Recombinant Anti-Helicobacter Pylori Antibody, Product Type & Application
2.7 Global Key Manufacturers of Recombinant Anti-Helicobacter Pylori Antibody, Date of Enter into This Industry
2.8 Global Recombinant Anti-Helicobacter Pylori Antibody Market Competitive Situation and Trends
2.8.1 Global Recombinant Anti-Helicobacter Pylori Antibody Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Recombinant Anti-Helicobacter Pylori Antibody Players Market Share by Revenue
2.8.3 Global Recombinant Anti-Helicobacter Pylori Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Recombinant Anti-Helicobacter Pylori Antibody Market Scenario by Region
3.1 Global Recombinant Anti-Helicobacter Pylori Antibody Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Region: 2020-2031
3.2.1 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Region: 2020-2025
3.2.2 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Region: 2026-2031
3.3 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region: 2020-2031
3.3.1 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region: 2020-2025
3.3.2 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region: 2026-2031
3.4 North America Recombinant Anti-Helicobacter Pylori Antibody Market Facts & Figures by Country
3.4.1 North America Recombinant Anti-Helicobacter Pylori Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2020-2031)
3.4.3 North America Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Recombinant Anti-Helicobacter Pylori Antibody Market Facts & Figures by Country
3.5.1 Europe Recombinant Anti-Helicobacter Pylori Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2020-2031)
3.5.3 Europe Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Market Facts & Figures by Region
3.6.1 Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Sales by Region (2020-2031)
3.6.3 Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Recombinant Anti-Helicobacter Pylori Antibody Market Facts & Figures by Country
3.7.1 Latin America Recombinant Anti-Helicobacter Pylori Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2020-2031)
3.7.3 Latin America Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Market Facts & Figures by Country
3.8.1 Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2020-2031)
3.8.3 Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Type (2020-2031)
4.1.1 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Type (2020-2025)
4.1.2 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Type (2026-2031)
4.1.3 Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Type (2020-2031)
4.2 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Type (2020-2031)
4.2.1 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Type (2020-2025)
4.2.2 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Type (2026-2031)
4.2.3 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Type (2020-2031)
4.3 Global Recombinant Anti-Helicobacter Pylori Antibody Price by Type (2020-2031)
5 Segment by Application
5.1 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Application (2020-2031)
5.1.1 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Application (2020-2025)
5.1.2 Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Application (2026-2031)
5.1.3 Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Application (2020-2031)
5.2 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Application (2020-2031)
5.2.1 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Application (2020-2025)
5.2.2 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Application (2026-2031)
5.2.3 Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Application (2020-2031)
5.3 Global Recombinant Anti-Helicobacter Pylori Antibody Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Thermo Fisher Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Ray Biotech
6.2.1 Ray Biotech Company Information
6.2.2 Ray Biotech Description and Business Overview
6.2.3 Ray Biotech Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ray Biotech Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.2.5 Ray Biotech Recent Developments/Updates
6.3 MyBioSource
6.3.1 MyBioSource Company Information
6.3.2 MyBioSource Description and Business Overview
6.3.3 MyBioSource Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.3.4 MyBioSource Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.3.5 MyBioSource Recent Developments/Updates
6.4 ImmunoDiagnostics
6.4.1 ImmunoDiagnostics Company Information
6.4.2 ImmunoDiagnostics Description and Business Overview
6.4.3 ImmunoDiagnostics Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.4.4 ImmunoDiagnostics Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.4.5 ImmunoDiagnostics Recent Developments/Updates
6.5 Hycult Biotech
6.5.1 Hycult Biotech Company Information
6.5.2 Hycult Biotech Description and Business Overview
6.5.3 Hycult Biotech Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hycult Biotech Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.5.5 Hycult Biotech Recent Developments/Updates
6.6 Fine Test
6.6.1 Fine Test Company Information
6.6.2 Fine Test Description and Business Overview
6.6.3 Fine Test Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Fine Test Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.6.5 Fine Test Recent Developments/Updates
6.7 Enzo Biochem
6.7.1 Enzo Biochem Company Information
6.7.2 Enzo Biochem Description and Business Overview
6.7.3 Enzo Biochem Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Enzo Biochem Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.7.5 Enzo Biochem Recent Developments/Updates
6.8 Eagle Diagnostics
6.8.1 Eagle Diagnostics Company Information
6.8.2 Eagle Diagnostics Description and Business Overview
6.8.3 Eagle Diagnostics Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Eagle Diagnostics Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.8.5 Eagle Diagnostics Recent Developments/Updates
6.9 Creative Biolabs
6.9.1 Creative Biolabs Company Information
6.9.2 Creative Biolabs Description and Business Overview
6.9.3 Creative Biolabs Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Creative Biolabs Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.9.5 Creative Biolabs Recent Developments/Updates
6.10 Boster Bio
6.10.1 Boster Bio Company Information
6.10.2 Boster Bio Description and Business Overview
6.10.3 Boster Bio Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Boster Bio Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.10.5 Boster Bio Recent Developments/Updates
6.11 BioVendor Group
6.11.1 BioVendor Group Company Information
6.11.2 BioVendor Group Description and Business Overview
6.11.3 BioVendor Group Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.11.4 BioVendor Group Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.11.5 BioVendor Group Recent Developments/Updates
6.12 Abcam
6.12.1 Abcam Company Information
6.12.2 Abcam Description and Business Overview
6.12.3 Abcam Recombinant Anti-Helicobacter Pylori Antibody Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Abcam Recombinant Anti-Helicobacter Pylori Antibody Product Portfolio
6.12.5 Abcam Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Recombinant Anti-Helicobacter Pylori Antibody Industry Chain Analysis
7.2 Recombinant Anti-Helicobacter Pylori Antibody Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Recombinant Anti-Helicobacter Pylori Antibody Production Mode & Process Analysis
7.4 Recombinant Anti-Helicobacter Pylori Antibody Sales and Marketing
7.4.1 Recombinant Anti-Helicobacter Pylori Antibody Sales Channels
7.4.2 Recombinant Anti-Helicobacter Pylori Antibody Distributors
7.5 Recombinant Anti-Helicobacter Pylori Antibody Customer Analysis
8 Recombinant Anti-Helicobacter Pylori Antibody Market Dynamics
8.1 Recombinant Anti-Helicobacter Pylori Antibody Industry Trends
8.2 Recombinant Anti-Helicobacter Pylori Antibody Market Drivers
8.3 Recombinant Anti-Helicobacter Pylori Antibody Market Challenges
8.4 Recombinant Anti-Helicobacter Pylori Antibody Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Recombinant Anti-Helicobacter Pylori Antibody Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Recombinant Anti-Helicobacter Pylori Antibody Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Recombinant Anti-Helicobacter Pylori Antibody Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Recombinant Anti-Helicobacter Pylori Antibody Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Recombinant Anti-Helicobacter Pylori Antibody, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Recombinant Anti-Helicobacter Pylori Antibody, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Recombinant Anti-Helicobacter Pylori Antibody, Product Type & Application
 Table 12. Global Key Manufacturers of Recombinant Anti-Helicobacter Pylori Antibody, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Recombinant Anti-Helicobacter Pylori Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Anti-Helicobacter Pylori Antibody as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Recombinant Anti-Helicobacter Pylori Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Region (2020-2025) & (K Units)
 Table 18. Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Region (2020-2025)
 Table 19. Global Recombinant Anti-Helicobacter Pylori Antibody Sales by Region (2026-2031) & (K Units)
 Table 20. Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Region (2026-2031)
 Table 21. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Region (2020-2025)
 Table 23. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Region (2026-2031)
 Table 25. North America Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2020-2025) & (K Units)
 Table 27. North America Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2026-2031) & (K Units)
 Table 28. North America Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units) by Type (2020-2025)
 Table 51. Global Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units) by Type (2026-2031)
 Table 52. Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Type (2020-2025)
 Table 53. Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Type (2026-2031)
 Table 54. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Type (2020-2025)
 Table 57. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Type (2026-2031)
 Table 58. Global Recombinant Anti-Helicobacter Pylori Antibody Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Recombinant Anti-Helicobacter Pylori Antibody Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units) by Application (2020-2025)
 Table 61. Global Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units) by Application (2026-2031)
 Table 62. Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Application (2020-2025)
 Table 63. Global Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Application (2026-2031)
 Table 64. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Application (2020-2025)
 Table 67. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Application (2026-2031)
 Table 68. Global Recombinant Anti-Helicobacter Pylori Antibody Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Recombinant Anti-Helicobacter Pylori Antibody Price (US$/Unit) by Application (2026-2031)
 Table 70. Thermo Fisher Company Information
 Table 71. Thermo Fisher Description and Business Overview
 Table 72. Thermo Fisher Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Thermo Fisher Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 74. Thermo Fisher Recent Developments/Updates
 Table 75. Ray Biotech Company Information
 Table 76. Ray Biotech Description and Business Overview
 Table 77. Ray Biotech Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Ray Biotech Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 79. Ray Biotech Recent Developments/Updates
 Table 80. MyBioSource Company Information
 Table 81. MyBioSource Description and Business Overview
 Table 82. MyBioSource Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. MyBioSource Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 84. MyBioSource Recent Developments/Updates
 Table 85. ImmunoDiagnostics Company Information
 Table 86. ImmunoDiagnostics Description and Business Overview
 Table 87. ImmunoDiagnostics Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. ImmunoDiagnostics Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 89. ImmunoDiagnostics Recent Developments/Updates
 Table 90. Hycult Biotech Company Information
 Table 91. Hycult Biotech Description and Business Overview
 Table 92. Hycult Biotech Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Hycult Biotech Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 94. Hycult Biotech Recent Developments/Updates
 Table 95. Fine Test Company Information
 Table 96. Fine Test Description and Business Overview
 Table 97. Fine Test Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Fine Test Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 99. Fine Test Recent Developments/Updates
 Table 100. Enzo Biochem Company Information
 Table 101. Enzo Biochem Description and Business Overview
 Table 102. Enzo Biochem Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Enzo Biochem Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 104. Enzo Biochem Recent Developments/Updates
 Table 105. Eagle Diagnostics Company Information
 Table 106. Eagle Diagnostics Description and Business Overview
 Table 107. Eagle Diagnostics Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Eagle Diagnostics Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 109. Eagle Diagnostics Recent Developments/Updates
 Table 110. Creative Biolabs Company Information
 Table 111. Creative Biolabs Description and Business Overview
 Table 112. Creative Biolabs Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Creative Biolabs Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 114. Creative Biolabs Recent Developments/Updates
 Table 115. Boster Bio Company Information
 Table 116. Boster Bio Description and Business Overview
 Table 117. Boster Bio Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Boster Bio Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 119. Boster Bio Recent Developments/Updates
 Table 120. BioVendor Group Company Information
 Table 121. BioVendor Group Description and Business Overview
 Table 122. BioVendor Group Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. BioVendor Group Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 124. BioVendor Group Recent Developments/Updates
 Table 125. Abcam Company Information
 Table 126. Abcam Description and Business Overview
 Table 127. Abcam Recombinant Anti-Helicobacter Pylori Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Abcam Recombinant Anti-Helicobacter Pylori Antibody Product
 Table 129. Abcam Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Recombinant Anti-Helicobacter Pylori Antibody Distributors List
 Table 133. Recombinant Anti-Helicobacter Pylori Antibody Customers List
 Table 134. Recombinant Anti-Helicobacter Pylori Antibody Market Trends
 Table 135. Recombinant Anti-Helicobacter Pylori Antibody Market Drivers
 Table 136. Recombinant Anti-Helicobacter Pylori Antibody Market Challenges
 Table 137. Recombinant Anti-Helicobacter Pylori Antibody Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Recombinant Anti-Helicobacter Pylori Antibody
 Figure 2. Global Recombinant Anti-Helicobacter Pylori Antibody Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Recombinant Anti-Helicobacter Pylori Antibody Market Share by Type: 2024 & 2031
 Figure 4. 1 mg Product Picture
 Figure 5. 2 mg Product Picture
 Figure 6. 5 mg Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global Recombinant Anti-Helicobacter Pylori Antibody Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Recombinant Anti-Helicobacter Pylori Antibody Market Share by Application: 2024 & 2031
 Figure 10. Medical Diagnosis
 Figure 11. Scientific Research
 Figure 12. Others
 Figure 13. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Recombinant Anti-Helicobacter Pylori Antibody Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Recombinant Anti-Helicobacter Pylori Antibody Sales (2020-2031) & (K Units)
 Figure 16. Global Recombinant Anti-Helicobacter Pylori Antibody Average Price (US$/Unit) & (2020-2031)
 Figure 17. Recombinant Anti-Helicobacter Pylori Antibody Report Years Considered
 Figure 18. Recombinant Anti-Helicobacter Pylori Antibody Sales Share by Manufacturers in 2024
 Figure 19. Global Recombinant Anti-Helicobacter Pylori Antibody Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Recombinant Anti-Helicobacter Pylori Antibody Players: Market Share by Revenue in Recombinant Anti-Helicobacter Pylori Antibody in 2024
 Figure 21. Recombinant Anti-Helicobacter Pylori Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Recombinant Anti-Helicobacter Pylori Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Country (2020-2031)
 Figure 24. North America Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Country (2020-2031)
 Figure 25. United States Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Country (2020-2031)
 Figure 28. Europe Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Region (2020-2031)
 Figure 36. China Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Recombinant Anti-Helicobacter Pylori Antibody Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Recombinant Anti-Helicobacter Pylori Antibody Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Recombinant Anti-Helicobacter Pylori Antibody by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Recombinant Anti-Helicobacter Pylori Antibody by Type (2020-2031)
 Figure 55. Global Recombinant Anti-Helicobacter Pylori Antibody Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Recombinant Anti-Helicobacter Pylori Antibody by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Recombinant Anti-Helicobacter Pylori Antibody by Application (2020-2031)
 Figure 58. Global Recombinant Anti-Helicobacter Pylori Antibody Price (US$/Unit) by Application (2020-2031)
 Figure 59. Recombinant Anti-Helicobacter Pylori Antibody Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS